Alzheimer’s and Parkinson’s Diseases: Expected Economic Impact on Europe—A Call for a Uniform European Strategy

Alzheimer's disease: Potential preventive, non-invasive, intervention strategies in lowering the risk of cognitive decline – A review study

(2015) Blanka Klimova et al.   Journal of Applied Biomedicine

Evaluation of full costs of care for patients with Alzheimer's disease in France: The predominant role of informal care

(2014) Chloé Gervès et al.   HEALTH POLICY

Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects

(2014) Eugenie Nepovimova et al.   JOURNAL OF MEDICINAL CHEMISTRY

Where, when, and in what form does sporadic Alzheimerʼs disease begin?

(2012) Heiko Braak et al.   CURRENT OPINION IN NEUROLOGY

An economic evaluation of early assessment for Alzheimer’s disease in the United Kingdom

(2011) Dennis Getsios et al.   Alzheimers & Dementia

Costs of Care for Dementia Patients in Community Setting: An Analysis for Mild and Moderate Disease Stage

(2011) Larissa Schwarzkopf et al.   VALUE IN HEALTH

The worldwide societal costs of dementia: Estimates for 2009

(2010) Anders Wimo et al.   Alzheimers & Dementia

Costs of Parkinson’s Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study

(2010) Yaroslav Winter et al.   Neurodegenerative Diseases

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

Costs of Parkinson's disease in Eastern Europe: A Czech cohort study

(2009) Yaroslav Winter et al.   PARKINSONISM & RELATED DISORDERS

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS